[
  {
    "title": "通化东宝(600867.SH)：超速效赖脯胰岛素注射液(THDB0206注射液)中国I期临床试验完成总结报告",
    "href": "http://stock.jrj.com.cn/2022/12/29153537246209.shtml",
    "datetime": "2022-12-29 15:35:32",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：THDBH151片申报临床获得批准",
    "href": "http://stock.jrj.com.cn/2022/12/22153337231277.shtml",
    "datetime": "2022-12-22 15:33:59",
    "code": "600867"
  },
  {
    "title": "科兴制药：获得通化东宝利拉鲁肽海外市场独家商业化许可",
    "href": "http://stock.jrj.com.cn/2022/12/06181737192592.shtml",
    "datetime": "2022-12-06 18:17:11",
    "code": "600867"
  },
  {
    "title": "通化东宝：门冬胰岛素30注射液和门冬胰岛素50注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14155937137026.shtml",
    "datetime": "2022-11-14 15:59:51",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：门冬胰岛素50注射液和门冬胰岛素30注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14155937137027.shtml",
    "datetime": "2022-11-14 15:59:07",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：第三季度净利降44.08%至2.20亿元",
    "href": "http://stock.jrj.com.cn/2022/10/30173937097458.shtml",
    "datetime": "2022-10-30 17:39:46",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)半年度权益分派10派2.5元、股权登记日为10月27日",
    "href": "http://stock.jrj.com.cn/2022/10/23170437075829.shtml",
    "datetime": "2022-10-23 17:04:49",
    "code": "600867"
  },
  {
    "title": "通化东宝：瑞格列奈片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/10/11154837046982.shtml",
    "datetime": "2022-10-11 15:48:07",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：瑞格列奈片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/10/11154737046988.shtml",
    "datetime": "2022-10-11 15:47:09",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解质及质押2500万股",
    "href": "http://stock.jrj.com.cn/2022/09/29154037030944.shtml",
    "datetime": "2022-09-29 15:40:18",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：THDBH151片申报临床获受理",
    "href": "http://stock.jrj.com.cn/2022/09/23155337017184.shtml",
    "datetime": "2022-09-23 15:53:03",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：德谷胰岛素注射液申报临床获得批准",
    "href": "http://stock.jrj.com.cn/2022/09/20153537007964.shtml",
    "datetime": "2022-09-20 15:35:06",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截至8月末已累计回购149.9977万股",
    "href": "http://stock.jrj.com.cn/2022/09/01153436962854.shtml",
    "datetime": "2022-09-01 15:34:10",
    "code": "600867"
  },
  {
    "title": "胰岛素集采冲击下通化东宝靠集采外市场及新产品能否打开新空间",
    "href": "http://stock.jrj.com.cn/2022/08/12074436893466.shtml",
    "datetime": "2022-08-12 07:44:00",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：截至7月末已累计回购120万股",
    "href": "http://stock.jrj.com.cn/2022/08/01153936859111.shtml",
    "datetime": "2022-08-01 15:39:52",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押2000万股 用于偿还贷款",
    "href": "http://stock.jrj.com.cn/2022/07/27201336848096.shtml",
    "datetime": "2022-07-27 20:13:22",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团质押2000万股",
    "href": "http://stock.jrj.com.cn/2022/07/27154036846924.shtml",
    "datetime": "2022-07-27 15:40:12",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：255.20万股限制性股票将于7月22日解锁上市",
    "href": "http://stock.jrj.com.cn/2022/07/18161336821346.shtml",
    "datetime": "2022-07-18 16:13:20",
    "code": "600867"
  },
  {
    "title": "通化东宝2022年半年预计净利13.64亿同比增加102.41% 投资收益增加",
    "href": "http://stock.jrj.com.cn/2022/07/14223236813249.shtml",
    "datetime": "2022-07-14 22:32:06",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截止6月末已累计回购120万股",
    "href": "http://stock.jrj.com.cn/2022/07/01161536775367.shtml",
    "datetime": "2022-07-01 16:15:26",
    "code": "600867"
  },
  {
    "title": "通化东宝以集中竞价交易方式首次回购公司120万股股份 成交总金额为1167.54万(不含交易费用)",
    "href": "http://stock.jrj.com.cn/2022/06/14205236729081.shtml",
    "datetime": "2022-06-14 20:52:34",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：首次回购120万股 涉资1167.537万元",
    "href": "http://stock.jrj.com.cn/2022/06/14160636727707.shtml",
    "datetime": "2022-06-14 16:06:00",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：2020.4万份股票期权可行权及255.2万股限制性股票可解锁",
    "href": "http://stock.jrj.com.cn/2022/06/09154736715802.shtml",
    "datetime": "2022-06-09 15:47:33",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：利拉鲁肽注射液上市许可注册申请已获国家药监局受理",
    "href": "http://stock.jrj.com.cn/2022/06/08155136712414.shtml",
    "datetime": "2022-06-08 15:51:13",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：2021年度权益分派10派3元 股权登记日为6月7日",
    "href": "http://stock.jrj.com.cn/2022/05/31163836693344.shtml",
    "datetime": "2022-05-31 16:38:51",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：THDB0207注射液德国I期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/05/18153736658633.shtml",
    "datetime": "2022-05-18 15:37:24",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：超速效赖脯胰岛素注射液中国III期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/05/09155236606764.shtml",
    "datetime": "2022-05-09 15:52:01",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：一季度净利润增146.90%至8.31亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28160336493177.shtml",
    "datetime": "2022-04-28 16:03:31",
    "code": "600867"
  },
  {
    "title": "通化东宝：URAT1抑制剂I期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/04/25161736463798.shtml",
    "datetime": "2022-04-25 16:17:46",
    "code": "600867"
  },
  {
    "title": "通化东宝2021年净利13.08亿同比增长40.69% 董事长冷春生薪酬377.68万",
    "href": "http://stock.jrj.com.cn/2022/04/19095036394654.shtml",
    "datetime": "2022-04-19 09:50:20",
    "code": "600867"
  },
  {
    "title": "通化东宝披露2021年年报 实现营收32.68亿元",
    "href": "http://stock.jrj.com.cn/2022/04/18214736387760.shtml",
    "datetime": "2022-04-18 21:47:26",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)2021年度净利润升40.69%至13.08亿元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2022/04/18195036387206.shtml",
    "datetime": "2022-04-18 19:50:22",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：可溶性甘精赖脯双胰岛素注射液(THDB0207注射液)德国I期临床试验申请获得批准",
    "href": "http://stock.jrj.com.cn/2022/04/11153836303762.shtml",
    "datetime": "2022-04-11 15:38:08",
    "code": "600867"
  },
  {
    "title": "通化东宝2022年一季度预计净利为8.17亿 同比增加143% 投资收益增加",
    "href": "http://stock.jrj.com.cn/2022/03/31185236241303.shtml",
    "datetime": "2022-03-31 18:52:46",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)一季度净利润预增142.63%",
    "href": "http://stock.jrj.com.cn/2022/03/31170936240373.shtml",
    "datetime": "2022-03-31 17:09:09",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超3.6亿元回购公司股份 用于减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2022/03/25205135150135.shtml",
    "datetime": "2022-03-25 20:51:52",
    "code": "600867"
  },
  {
    "title": "通化东宝：拟协议转让特宝生物部分股权 转让价为20.16元/股",
    "href": "http://stock.jrj.com.cn/2022/03/18133634844538.shtml",
    "datetime": "2022-03-18 13:36:54",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：可溶性甘精赖脯双胰岛素注射液(THDB0207注射液)申报临床获得批准",
    "href": "http://stock.jrj.com.cn/2022/03/10153634808631.shtml",
    "datetime": "2022-03-10 15:36:30",
    "code": "600867"
  },
  {
    "title": "A股异动 | 通化东宝(600867.SH)涨4% 拟回购1200万-2400万股",
    "href": "http://stock.jrj.com.cn/2022/03/10100934807507.shtml",
    "datetime": "2022-03-10 10:09:06",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超3.6亿元回购公司股份 用于减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2022/03/09225334643408.shtml",
    "datetime": "2022-03-09 22:53:59",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：拟回购1200万-2400万股公司股份",
    "href": "http://stock.jrj.com.cn/2022/03/09183534585376.shtml",
    "datetime": "2022-03-09 18:35:48",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：恩格列净片申报生产获得受理通知",
    "href": "http://stock.jrj.com.cn/2022/02/09154134313318.shtml",
    "datetime": "2022-02-09 15:41:16",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：完成回购 已累计回购1.18%股份",
    "href": "http://stock.jrj.com.cn/2022/02/07185334302708.shtml",
    "datetime": "2022-02-07 18:53:37",
    "code": "600867"
  },
  {
    "title": "通化东宝：西格列汀二甲双胍片增加规格的注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/02/07154134301026.shtml",
    "datetime": "2022-02-07 15:41:53",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：西格列汀二甲双胍片增加规格的药品注册补充申请获受理",
    "href": "http://stock.jrj.com.cn/2022/02/07153534300638.shtml",
    "datetime": "2022-02-07 15:35:02",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：收到恩格列净原料药备案受理通知书",
    "href": "http://stock.jrj.com.cn/2022/01/25153734209906.shtml",
    "datetime": "2022-01-25 15:37:39",
    "code": "600867"
  },
  {
    "title": "通化东宝2021年净利13.34亿 同比增长43.40% 产品收益增长",
    "href": "http://stock.jrj.com.cn/2022/01/24175134205291.shtml",
    "datetime": "2022-01-24 17:51:03",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)业绩快报：2021年度归母净利增43.40%至13.34亿元",
    "href": "http://stock.jrj.com.cn/2022/01/24171234204921.shtml",
    "datetime": "2022-01-24 17:12:02",
    "code": "600867"
  },
  {
    "title": "特宝生物股东通化东宝减持1623.5万股 套现3.94亿 2021年第三季度公司净利5558.36万",
    "href": "http://stock.jrj.com.cn/2022/01/14183034158604.shtml",
    "datetime": "2022-01-14 18:30:24",
    "code": "600867"
  },
  {
    "title": "特宝生物(688278.SH)：通化东宝完成减持3.99%股份",
    "href": "http://stock.jrj.com.cn/2022/01/14165934158058.shtml",
    "datetime": "2022-01-14 16:59:03",
    "code": "600867"
  },
  {
    "title": "特宝生物(688278.SH)：通化东宝自9月10日起累计减持1.22%股份",
    "href": "http://stock.jrj.com.cn/2022/01/07185334134525.shtml",
    "datetime": "2022-01-07 18:53:04",
    "code": "600867"
  },
  {
    "title": "通化东宝密集减持特宝生物 套现7.17亿支持创新药发展",
    "href": "http://stock.jrj.com.cn/2022/01/07073634131972.shtml",
    "datetime": "2022-01-07 07:36:15",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团解押1390万股及再质押1550万股",
    "href": "http://stock.jrj.com.cn/2022/01/05183234124730.shtml",
    "datetime": "2022-01-05 18:32:33",
    "code": "600867"
  },
  {
    "title": "特宝生物(688278.SH)：股东通化东宝拟将5%股份协议转让予青岛鼎兴启光",
    "href": "http://stock.jrj.com.cn/2022/01/05182734124655.shtml",
    "datetime": "2022-01-05 18:27:54",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：拟以4.60亿元协议转让特宝生物5%股份",
    "href": "http://stock.jrj.com.cn/2022/01/05182634124653.shtml",
    "datetime": "2022-01-05 18:26:03",
    "code": "600867"
  },
  {
    "title": "通化东宝：可溶性甘精赖脯双胰岛素注射液申报临床获受理",
    "href": "http://stock.jrj.com.cn/2021/12/27163434070949.shtml",
    "datetime": "2021-12-27 16:34:03",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：可溶性甘精赖脯双胰岛素注射液申报临床获得受理",
    "href": "http://stock.jrj.com.cn/2021/12/27154134070203.shtml",
    "datetime": "2021-12-27 15:41:59",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：URAT1抑制剂(THDBH130片)申报临床获得批准",
    "href": "http://stock.jrj.com.cn/2021/12/16160734024525.shtml",
    "datetime": "2021-12-16 16:07:52",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团解质919万股及质押2835万股",
    "href": "http://stock.jrj.com.cn/2021/12/10161133994710.shtml",
    "datetime": "2021-12-10 16:11:17",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截止11月末已累计回购1999.9646万股",
    "href": "http://stock.jrj.com.cn/2021/12/01154733949814.shtml",
    "datetime": "2021-12-01 15:47:30",
    "code": "600867"
  },
  {
    "title": "通化东宝聘任杜治强为副总经理 第三季度公司净利3.94亿",
    "href": "http://stock.jrj.com.cn/2021/11/30183233945181.shtml",
    "datetime": "2021-11-30 18:32:08",
    "code": "600867"
  },
  {
    "title": "【龙虎榜】通化东宝11月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/26180533924366.shtml",
    "datetime": "2021-11-26 18:05:44",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解质900万股及再质押1600万股",
    "href": "http://stock.jrj.com.cn/2021/11/26162833923809.shtml",
    "datetime": "2021-11-26 16:28:31",
    "code": "600867"
  },
  {
    "title": "通化东宝：多个规格产品拟中标全国药品集采（胰岛素专项）",
    "href": "http://stock.jrj.com.cn/2021/11/26162733923802.shtml",
    "datetime": "2021-11-26 16:27:29",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：人胰岛素注射液等5个产品拟中标第六批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/11/26161533923779.shtml",
    "datetime": "2021-11-26 16:15:24",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押2000万股",
    "href": "http://stock.jrj.com.cn/2021/11/24154033914271.shtml",
    "datetime": "2021-11-24 15:40:19",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东质押及解质900万股",
    "href": "http://stock.jrj.com.cn/2021/11/17154233866202.shtml",
    "datetime": "2021-11-17 15:42:33",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截止10月末累计回购1199.9766万股",
    "href": "http://stock.jrj.com.cn/2021/11/01153433797315.shtml",
    "datetime": "2021-11-01 15:34:54",
    "code": "600867"
  },
  {
    "title": "A股异动 | 通化东宝(600867.SH)涨4.7% 三季度利润大增叠加券商看好",
    "href": "http://stock.jrj.com.cn/2021/10/28095033767325.shtml",
    "datetime": "2021-10-28 09:50:33",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)第三季度净利润3.94亿元 同比增长83.72%",
    "href": "http://stock.jrj.com.cn/2021/10/27205533764260.shtml",
    "datetime": "2021-10-27 20:55:36",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：西格列汀二甲双胍片(Ⅱ)获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/10/20180533722759.shtml",
    "datetime": "2021-10-20 18:05:54",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：门冬胰岛素注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/10/20180333722732.shtml",
    "datetime": "2021-10-20 18:03:36",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团解押1838万股及质押1000万股",
    "href": "http://stock.jrj.com.cn/2021/10/14154633690857.shtml",
    "datetime": "2021-10-14 15:46:07",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：超速效赖脯胰岛素注射液(BCLispro)申报平行开展III期临床与Ⅰ期临床获得批准",
    "href": "http://stock.jrj.com.cn/2021/10/13172633685511.shtml",
    "datetime": "2021-10-13 17:26:59",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：URAT1抑制剂(THDBH130片)申报临床获得受理",
    "href": "http://stock.jrj.com.cn/2021/10/12182333680402.shtml",
    "datetime": "2021-10-12 18:23:44",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截止9月末已累计回购1199.9766万股",
    "href": "http://stock.jrj.com.cn/2021/10/08165333657999.shtml",
    "datetime": "2021-10-08 16:53:55",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押3100万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/09/30191433544465.shtml",
    "datetime": "2021-09-30 19:14:08",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团质押合计3100万股",
    "href": "http://stock.jrj.com.cn/2021/09/30161033543178.shtml",
    "datetime": "2021-09-30 16:10:31",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团解质1800万股及质押1800万股",
    "href": "http://stock.jrj.com.cn/2021/09/28161133530568.shtml",
    "datetime": "2021-09-28 16:11:13",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：相关方解除一致行动关系 公司实控人变更为李一奎",
    "href": "http://stock.jrj.com.cn/2021/09/17165733452036.shtml",
    "datetime": "2021-09-17 16:57:06",
    "code": "600867"
  },
  {
    "title": "特宝生物(688278.SH)：减持数过半 通化东宝已减持1.99%股份",
    "href": "http://stock.jrj.com.cn/2021/09/08164133404493.shtml",
    "datetime": "2021-09-08 16:41:59",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：拟使用部分闲置募集资金3亿元暂补流动资金",
    "href": "http://stock.jrj.com.cn/2021/09/08160233404285.shtml",
    "datetime": "2021-09-08 16:02:11",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：磷酸西格列汀片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/09/06154233392157.shtml",
    "datetime": "2021-09-06 15:42:23",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东质押1390万股",
    "href": "http://stock.jrj.com.cn/2021/09/02212633376131.shtml",
    "datetime": "2021-09-02 21:26:41",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押1390万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/09/02185233375408.shtml",
    "datetime": "2021-09-02 18:52:48",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：首次回购200万股 涉资2111.12万元",
    "href": "http://stock.jrj.com.cn/2021/09/02160333374510.shtml",
    "datetime": "2021-09-02 16:03:19",
    "code": "600867"
  },
  {
    "title": "因公司经营发展需要，通化东宝拟出售特宝生物4%股份",
    "href": "http://stock.jrj.com.cn/2021/08/31114333359760.shtml",
    "datetime": "2021-08-31 11:43:44",
    "code": "600867"
  },
  {
    "title": "特宝生物(688278.SH)：持股30.06%的通化东宝拟减持不超4%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/30184133354039.shtml",
    "datetime": "2021-08-30 18:41:13",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超3.6亿元回购公司股份 用于减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2021/08/25193233318245.shtml",
    "datetime": "2021-08-25 19:32:33",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)半年度净利润6.74亿元 同比增长24.47%",
    "href": "http://stock.jrj.com.cn/2021/08/24155333310067.shtml",
    "datetime": "2021-08-24 15:53:18",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超3.6亿元回购公司股份 用于注销减少公司注册资本",
    "href": "http://stock.jrj.com.cn/2021/07/29213933171606.shtml",
    "datetime": "2021-07-29 21:39:42",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：拟回购1200万股-2400万股 回购金额不超3.6亿元",
    "href": "http://stock.jrj.com.cn/2021/07/29185533170653.shtml",
    "datetime": "2021-07-29 18:55:08",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解质2600万股及质押2200万股",
    "href": "http://stock.jrj.com.cn/2021/07/21153633129916.shtml",
    "datetime": "2021-07-21 15:36:26",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：预混型门冬胰岛素注射液获得报产受理通知",
    "href": "http://stock.jrj.com.cn/2021/07/14154033094774.shtml",
    "datetime": "2021-07-14 15:40:48",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：与上海药明康德就两项创新药签署技术转让合同",
    "href": "http://stock.jrj.com.cn/2021/06/30183633022812.shtml",
    "datetime": "2021-06-30 18:36:59",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押3600万股及再质押1550万股",
    "href": "http://stock.jrj.com.cn/2021/06/29153933015766.shtml",
    "datetime": "2021-06-29 15:39:59",
    "code": "600867"
  },
  {
    "title": "通化东宝新药获批 研发费用增三成 去库存完成 业绩增长将继续",
    "href": "http://stock.jrj.com.cn/2021/06/29090833014777.shtml",
    "datetime": "2021-06-29 09:08:00",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：三靶点抑制剂产品(THDBH101)临床申报获批",
    "href": "http://stock.jrj.com.cn/2021/06/28155333010209.shtml",
    "datetime": "2021-06-28 15:53:33",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司董事长冷总及管理层全体成员均正常履职",
    "href": "http://stock.jrj.com.cn/2021/06/24130932988940.shtml",
    "datetime": "2021-06-24 13:09:32",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司预计近期可以提交NDA申请",
    "href": "http://stock.jrj.com.cn/2021/06/21142032969162.shtml",
    "datetime": "2021-06-21 14:20:49",
    "code": "600867"
  },
  {
    "title": "通化东宝：在研产品磷酸西格列汀片、西格列汀二甲双胍片正在国家药品监督管理局审批阶段 预计年内可获批",
    "href": "http://stock.jrj.com.cn/2021/06/21142032969158.shtml",
    "datetime": "2021-06-21 14:20:39",
    "code": "600867"
  },
  {
    "title": "通化东宝：在研产品可溶性甘精赖脯双胰岛素注射液（THDB0207）沟通交流会议申请暂未收到CDE全部回复",
    "href": "http://stock.jrj.com.cn/2021/06/21142032969157.shtml",
    "datetime": "2021-06-21 14:20:25",
    "code": "600867"
  },
  {
    "title": "通化东宝：在研产品超速效赖脯胰岛素（THDB0206）正在积极筹划III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/21142032969159.shtml",
    "datetime": "2021-06-21 14:20:15",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：瑞格列奈片申报生产获得受理",
    "href": "http://stock.jrj.com.cn/2021/06/10154632905221.shtml",
    "datetime": "2021-06-10 15:46:13",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押1650万股 用于偿还债务",
    "href": "http://stock.jrj.com.cn/2021/06/09185932900875.shtml",
    "datetime": "2021-06-09 18:59:34",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东质押1650万股",
    "href": "http://stock.jrj.com.cn/2021/06/09161632899964.shtml",
    "datetime": "2021-06-09 16:16:07",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司三代甘精胰岛素自去年2月已上市销售",
    "href": "http://stock.jrj.com.cn/2021/06/01134632856324.shtml",
    "datetime": "2021-06-01 13:46:30",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押及再质押1467万股",
    "href": "http://stock.jrj.com.cn/2021/05/26154432823167.shtml",
    "datetime": "2021-05-26 15:44:23",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：2020年度权益分派10派2.1元 股权登记日为5月28日",
    "href": "http://stock.jrj.com.cn/2021/05/24174632811368.shtml",
    "datetime": "2021-05-24 17:46:05",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押800万股及再质押919万股",
    "href": "http://stock.jrj.com.cn/2021/05/21155532793486.shtml",
    "datetime": "2021-05-21 15:55:53",
    "code": "600867"
  },
  {
    "title": "通化东宝2021年第一季度净利增长21.33% 研发费用增长",
    "href": "http://stock.jrj.com.cn/2021/04/26221832456817.shtml",
    "datetime": "2021-04-26 22:18:46",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：一季度净利升21.33%至3.37亿元",
    "href": "http://stock.jrj.com.cn/2021/04/26155632454236.shtml",
    "datetime": "2021-04-26 15:56:31",
    "code": "600867"
  },
  {
    "title": "通化东宝：甘精胰岛素在2020年实现了1.3亿元销售收入 迄今为止已成功挂网25个省份",
    "href": "http://stock.jrj.com.cn/2021/04/26095632452087.shtml",
    "datetime": "2021-04-26 09:56:17",
    "code": "600867"
  },
  {
    "title": "通化东宝2020年净利增长14.63% 董事长冷春生薪酬377.68万",
    "href": "http://stock.jrj.com.cn/2021/04/16174732387564.shtml",
    "datetime": "2021-04-16 17:47:01",
    "code": "600867"
  },
  {
    "title": "通化东宝：通化东宝拥有糖尿病全病程一体化管理平台",
    "href": "http://stock.jrj.com.cn/2021/04/02152632270421.shtml",
    "datetime": "2021-04-02 15:26:55",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：东宝集团解除质押4320万股",
    "href": "http://stock.jrj.com.cn/2021/03/30153832247961.shtml",
    "datetime": "2021-03-30 15:38:35",
    "code": "600867"
  },
  {
    "title": "传闻胰岛素将专项集采 通化东宝“围绕糖尿病布局”战略或面临大考",
    "href": "http://stock.jrj.com.cn/2021/03/25072132213073.shtml",
    "datetime": "2021-03-25 07:21:13",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司目前还未收到任何关于胰岛素集采的通知或方案",
    "href": "http://stock.jrj.com.cn/2021/03/12082332113279.shtml",
    "datetime": "2021-03-12 08:23:34",
    "code": "600867"
  },
  {
    "title": "通化东宝：在研管线中的产品还覆盖GLP-1激动剂和化学口服类降糖药物包括SGLT-2和DPP4",
    "href": "http://stock.jrj.com.cn/2021/03/10144032103329.shtml",
    "datetime": "2021-03-10 14:40:37",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)与上海药明康德签署战略合作备忘录暨创新药项目合作",
    "href": "http://stock.jrj.com.cn/2021/03/05183632079553.shtml",
    "datetime": "2021-03-05 18:36:16",
    "code": "600867"
  },
  {
    "title": "通化东宝：与上海药明康德签署战略合作备忘录并建立创新药项目合作",
    "href": "http://stock.jrj.com.cn/2021/03/05183532079550.shtml",
    "datetime": "2021-03-05 18:35:42",
    "code": "600867"
  },
  {
    "title": "解质押后再质押 通化东宝质押率下降 业绩增长能否改善财务状况？",
    "href": "http://stock.jrj.com.cn/2021/03/04100632091623.shtml",
    "datetime": "2021-03-04 10:06:00",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押2.29亿股及再质押2.22亿股",
    "href": "http://stock.jrj.com.cn/2021/03/03153732063638.shtml",
    "datetime": "2021-03-03 15:37:50",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)截止2月末已累计回购665.3803万股",
    "href": "http://stock.jrj.com.cn/2021/03/01154532050316.shtml",
    "datetime": "2021-03-01 15:45:05",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押3480万股",
    "href": "http://stock.jrj.com.cn/2021/02/18154131986301.shtml",
    "datetime": "2021-02-18 15:41:37",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)首次回购97.71万股 涉资1151.36万元",
    "href": "http://stock.jrj.com.cn/2021/02/05154831854713.shtml",
    "datetime": "2021-02-05 15:48:26",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超1.6亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/02/02203931838922.shtml",
    "datetime": "2021-02-02 20:39:05",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝战略合作伙伴Adocia超速效赖脯胰岛素注射液(BC Lispro)临床研究取得积极成果",
    "href": "http://stock.jrj.com.cn/2021/01/26000031783526.shtml",
    "datetime": "2021-01-26 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝投资1亿元设立杭州创新药研发中心",
    "href": "http://stock.jrj.com.cn/2021/01/21192331739284.shtml",
    "datetime": "2021-01-21 19:23:48",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：拟投资设立杭州创新药研发中心",
    "href": "http://stock.jrj.com.cn/2021/01/21172931737729.shtml",
    "datetime": "2021-01-21 17:29:07",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解押4012.34万股及再质押2000万股",
    "href": "http://stock.jrj.com.cn/2021/01/15154731698571.shtml",
    "datetime": "2021-01-15 15:47:33",
    "code": "600867"
  },
  {
    "title": "通化东宝2020年净利9.29亿增长14.51% 销售收入稳步增长",
    "href": "http://stock.jrj.com.cn/2021/01/14194831693465.shtml",
    "datetime": "2021-01-14 19:48:34",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)业绩快报：2020年度净利升14.51%至9.29亿元",
    "href": "http://stock.jrj.com.cn/2021/01/14165531692322.shtml",
    "datetime": "2021-01-14 16:55:02",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东质押近九成持股 两胰岛素决定未来业绩",
    "href": "http://stock.jrj.com.cn/2021/01/12083531674678.shtml",
    "datetime": "2021-01-12 08:35:00",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东质押近九成持股 两胰岛素决定未来业绩",
    "href": "http://stock.jrj.com.cn/2021/01/12083531690481.shtml",
    "datetime": "2021-01-12 08:35:00",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押6100万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/01/11202031672040.shtml",
    "datetime": "2021-01-11 20:20:18",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：控股股东解除质押2亿股及再质押1.35亿股",
    "href": "http://stock.jrj.com.cn/2020/12/29153731595429.shtml",
    "datetime": "2020-12-29 15:37:54",
    "code": "600867"
  },
  {
    "title": "又一重磅交易落定！德弘资本再出手 押注浩云长盛 长期看好五大领域",
    "href": "http://stock.jrj.com.cn/2020/12/23103831552519.shtml",
    "datetime": "2020-12-23 10:38:07",
    "code": "600867"
  },
  {
    "title": "通化东宝原董事常晓慧遭监管关注 配偶短线交易",
    "href": "http://stock.jrj.com.cn/2020/12/17180931510779.shtml",
    "datetime": "2020-12-17 18:09:00",
    "code": "600867"
  },
  {
    "title": "通化东宝控股股东东宝集团质押3400万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/12/14212631489292.shtml",
    "datetime": "2020-12-14 21:26:10",
    "code": "600867"
  },
  {
    "title": "通化东宝：目前该项目处于前期的药理及处方开发阶段",
    "href": "http://stock.jrj.com.cn/2020/12/08155231440096.shtml",
    "datetime": "2020-12-08 15:52:23",
    "code": "600867"
  },
  {
    "title": "通化东宝超速效赖脯胰岛素注射液申报临床获得批准通知",
    "href": "http://stock.jrj.com.cn/2020/11/22155231331342.shtml",
    "datetime": "2020-11-22 15:52:29",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：超速效赖脯胰岛素注射液申报临床获得批准",
    "href": "http://stock.jrj.com.cn/2020/11/22150931331275.shtml",
    "datetime": "2020-11-22 15:09:15",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝「超速效赖脯胰岛素注射液」获批临床",
    "href": "http://stock.jrj.com.cn/2020/11/21000031337506.shtml",
    "datetime": "2020-11-21 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：门冬胰岛素30注射液已于2020年6月完成全部病例的入组 计划2020年12 月完成全部病例的出组",
    "href": "http://stock.jrj.com.cn/2020/11/13193231277085.shtml",
    "datetime": "2020-11-13 19:32:55",
    "code": "600867"
  },
  {
    "title": "通化东宝前三季度净利7.56亿增长9.82% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/28214531152679.shtml",
    "datetime": "2020-10-28 21:45:08",
    "code": "600867"
  },
  {
    "title": "通化东宝：第十届董事会第七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/23001031111840.shtml",
    "datetime": "2020-10-23 00:10:39",
    "code": "600867"
  },
  {
    "title": "通化东宝：异地建设重组人胰岛素项目建设地点位于通化市通化医药高新技术产业开发区（湾湾川）",
    "href": "http://stock.jrj.com.cn/2020/10/09110231008430.shtml",
    "datetime": "2020-10-09 11:02:44",
    "code": "600867"
  },
  {
    "title": "通化东宝：第十届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/09/30001030862314.shtml",
    "datetime": "2020-09-30 00:10:52",
    "code": "600867"
  },
  {
    "title": "通化东宝：召开2020年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/09/30001030862313.shtml",
    "datetime": "2020-09-30 00:10:51",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝药业股份有限公司党委成立同时召开第一次党员大会",
    "href": "http://stock.jrj.com.cn/2020/09/29000030860154.shtml",
    "datetime": "2020-09-29 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝药业股份有限公司召开2020年第一次临时股东大会",
    "href": "http://stock.jrj.com.cn/2020/09/29000030860155.shtml",
    "datetime": "2020-09-29 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)控股股东解押4558万股及质押5000万股",
    "href": "http://stock.jrj.com.cn/2020/09/23171630818478.shtml",
    "datetime": "2020-09-23 17:16:28",
    "code": "600867"
  },
  {
    "title": "通化东宝：2020年第一次临时股东大会的延期公告",
    "href": "http://stock.jrj.com.cn/2020/09/17001030765169.shtml",
    "datetime": "2020-09-17 00:10:47",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司的销售回款没有季节性，主要和上季度的发货相关",
    "href": "http://stock.jrj.com.cn/2020/09/15141330754793.shtml",
    "datetime": "2020-09-15 14:13:49",
    "code": "600867"
  },
  {
    "title": "通化东宝：重组人胰岛素生产基地异地建设“项目实施的风险和收益存在一定不确定性",
    "href": "http://stock.jrj.com.cn/2020/09/15141330754792.shtml",
    "datetime": "2020-09-15 14:13:28",
    "code": "600867"
  },
  {
    "title": "通化东宝：全院血糖管理的POCT项目促进了胰岛素业务的开展 也加强了公司和医院合作的粘性",
    "href": "http://stock.jrj.com.cn/2020/09/15135430754706.shtml",
    "datetime": "2020-09-15 13:54:51",
    "code": "600867"
  },
  {
    "title": "通化东宝：全院血糖管理的 POCT 项目主要由东宝投资华广提供设备和部分服务",
    "href": "http://stock.jrj.com.cn/2020/09/15135330754696.shtml",
    "datetime": "2020-09-15 13:53:41",
    "code": "600867"
  },
  {
    "title": "通化东宝：日前建材行业已停止新订单接收公司正在积极推进从建材行业退出的相关事宜",
    "href": "http://stock.jrj.com.cn/2020/09/15135230754694.shtml",
    "datetime": "2020-09-15 13:52:15",
    "code": "600867"
  },
  {
    "title": "通化东宝：丽景花园未售房产面积约为6万余平方米公司正在谋求项目的整体转让事宜",
    "href": "http://stock.jrj.com.cn/2020/09/15135130754697.shtml",
    "datetime": "2020-09-15 13:51:46",
    "code": "600867"
  },
  {
    "title": "通化东宝股东拟卖股 上交所：业绩承诺净利飙有悖趋势",
    "href": "http://stock.jrj.com.cn/2020/09/14115430746614.shtml",
    "datetime": "2020-09-14 11:54:00",
    "code": "600867"
  },
  {
    "title": "控股股东转让股权中承诺业绩大增 通化东宝遭监管问询",
    "href": "http://stock.jrj.com.cn/2020/09/11154530730040.shtml",
    "datetime": "2020-09-11 15:45:07",
    "code": "600867"
  },
  {
    "title": "A股异动丨通化东宝(600867.SH)涨近6% 获德弘资本以19.4亿元战略入股",
    "href": "http://stock.jrj.com.cn/2020/09/11094230728032.shtml",
    "datetime": "2020-09-11 09:42:08",
    "code": "600867"
  },
  {
    "title": "通化东宝(600867.SH)：德弘开远将间接持有公司约9%的股份",
    "href": "http://stock.jrj.com.cn/2020/09/10201630723365.shtml",
    "datetime": "2020-09-10 20:16:47",
    "code": "600867"
  },
  {
    "title": "通化东宝继续大涨！券商：三代甘精胰岛素持续放量中",
    "href": "http://stock.jrj.com.cn/2020/08/21133530556840.shtml",
    "datetime": "2020-08-21 13:35:45",
    "code": "600867"
  },
  {
    "title": "通化东宝上半年净利润达5.4亿元：同比增幅1.73% 盘中一度涨超4%",
    "href": "http://stock.jrj.com.cn/2020/08/20101330547073.shtml",
    "datetime": "2020-08-20 10:13:47",
    "code": "600867"
  },
  {
    "title": "通化东宝上半年实现净利5.41亿元同比增1.73%",
    "href": "http://stock.jrj.com.cn/2020/08/20041030542285.shtml",
    "datetime": "2020-08-20 04:10:19",
    "code": "600867"
  },
  {
    "title": "通化东宝2020年上半年净利5.41亿增长1.73% 营业成本下滑",
    "href": "http://stock.jrj.com.cn/2020/08/19191330540702.shtml",
    "datetime": "2020-08-19 19:13:49",
    "code": "600867"
  },
  {
    "title": "通化东宝副总经理韩凤军辞职",
    "href": "http://stock.jrj.com.cn/2020/08/10222230468300.shtml",
    "datetime": "2020-08-10 22:22:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司生产的胰蛋白酶主要自用 目前没有对外销售",
    "href": "http://stock.jrj.com.cn/2020/08/07113930448772.shtml",
    "datetime": "2020-08-07 11:39:04",
    "code": "600867"
  },
  {
    "title": "千亿医药龙头连续三跌停，这是什么风向？业绩超预期股名单来了，最强预增超25倍，外资大笔加仓10股",
    "href": "http://stock.jrj.com.cn/2020/07/20123730291828.shtml",
    "datetime": "2020-07-20 12:37:55",
    "code": "600867"
  },
  {
    "title": "快讯：通化东宝急速拉升5.43% 主力资金净流入151.60万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30094530094284.shtml",
    "datetime": "2020-06-30 09:45:51",
    "code": "600867"
  },
  {
    "title": "快讯：通化东宝急速拉升5.43% 主力资金净流入916.12万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30094430094260.shtml",
    "datetime": "2020-06-30 09:44:12",
    "code": "600867"
  },
  {
    "title": "业绩下滑快股东质押忙 通化东宝甘精胰岛素能否带来转机？",
    "href": "http://stock.jrj.com.cn/2020/06/28080030062973.shtml",
    "datetime": "2020-06-28 08:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝聘任苏璠担任副总经理及董事会秘书",
    "href": "http://stock.jrj.com.cn/2020/06/17190529950960.shtml",
    "datetime": "2020-06-17 19:05:57",
    "code": "600867"
  },
  {
    "title": "[财经天眼]胰岛素双雄会：毛利率比肩茅台 曾8亿行贿医生 甘李药业苦等800天终获批文， 通化东宝慌了？",
    "href": "http://stock.jrj.com.cn/2020/06/09132829879906.shtml",
    "datetime": "2020-06-09 13:28:36",
    "code": "600867"
  },
  {
    "title": "通化东宝：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/05/19073029708300.shtml",
    "datetime": "2020-05-19 07:30:02",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1590万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/05/15214229684279.shtml",
    "datetime": "2020-05-15 21:42:44",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝药业股份有限公司召开2019年年度股东大会",
    "href": "http://stock.jrj.com.cn/2020/05/08000029620155.shtml",
    "datetime": "2020-05-08 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团减持1753.99万股 套现约2.34亿元",
    "href": "http://stock.jrj.com.cn/2020/04/26211829378838.shtml",
    "datetime": "2020-04-26 21:18:27",
    "code": "600867"
  },
  {
    "title": "通化东宝：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/24004029361804.shtml",
    "datetime": "2020-04-24 00:40:06",
    "code": "600867"
  },
  {
    "title": "“心机婊”通化东宝：有11.5亿现金流还借钱，差旅费超研发费5.3倍",
    "href": "http://stock.jrj.com.cn/2020/04/15085029293782.shtml",
    "datetime": "2020-04-15 08:50:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]同心协力 抗击疫情 通化东宝向通化市红十字会捐赠价值2200万元药品和100万元现金",
    "href": "http://stock.jrj.com.cn/2020/02/23000028879115.shtml",
    "datetime": "2020-02-23 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化重点项目:通化东宝的三代胰岛素首发上市销售",
    "href": "http://stock.jrj.com.cn/2020/02/05000028775861.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]守护武汉 共克时艰 通化东宝向中国红十字基金会捐赠1,000,000元人民币",
    "href": "http://stock.jrj.com.cn/2020/01/28000028750294.shtml",
    "datetime": "2020-01-28 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：特宝生物明日科创板上市 公司对其投资1.56亿元",
    "href": "http://stock.jrj.com.cn/2020/01/16174128687560.shtml",
    "datetime": "2020-01-16 17:41:27",
    "code": "600867"
  },
  {
    "title": "通化东宝：参股公司特宝生物在科创板上市",
    "href": "http://stock.jrj.com.cn/2020/01/16170428687365.shtml",
    "datetime": "2020-01-16 17:04:28",
    "code": "600867"
  },
  {
    "title": "[通化东宝]突破!通化重组人白蛋白注射液项目开展Ⅰb期临床试验",
    "href": "http://stock.jrj.com.cn/2020/01/08000028643505.shtml",
    "datetime": "2020-01-08 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝首次回购逾7500万元股份",
    "href": "http://stock.jrj.com.cn/2019/12/26215728592449.shtml",
    "datetime": "2019-12-26 21:57:10",
    "code": "600867"
  },
  {
    "title": "通化东宝：首次回购0.3%股份 耗资逾7500万元",
    "href": "http://stock.jrj.com.cn/2019/12/26173028591162.shtml",
    "datetime": "2019-12-26 17:30:11",
    "code": "600867"
  },
  {
    "title": "通化东宝：首次回购逾7500万元股份",
    "href": "http://stock.jrj.com.cn/2019/12/26162828590904.shtml",
    "datetime": "2019-12-26 16:28:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/24011028575142.shtml",
    "datetime": "2019-12-24 01:10:03",
    "code": "600867"
  },
  {
    "title": "[通化东宝]关于甘精胰岛素注射液获得药品注册批件的公告",
    "href": "http://stock.jrj.com.cn/2019/12/12000028523475.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：关于2019年第一次临时股东大会的延期公告",
    "href": "http://stock.jrj.com.cn/2019/12/11230028521634.shtml",
    "datetime": "2019-12-11 23:00:31",
    "code": "600867"
  },
  {
    "title": "通化东宝甘精胰岛素注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/11180828520259.shtml",
    "datetime": "2019-12-11 18:08:50",
    "code": "600867"
  },
  {
    "title": "通化东宝：甘精胰岛素注射液获药品注册批件 用于降低患者血糖",
    "href": "http://stock.jrj.com.cn/2019/12/11171628520008.shtml",
    "datetime": "2019-12-11 17:16:42",
    "code": "600867"
  },
  {
    "title": "通化东宝：甘精胰岛素注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/11165128519911.shtml",
    "datetime": "2019-12-11 16:51:37",
    "code": "600867"
  },
  {
    "title": "通化东宝股东李凤芹减持5万股 套现约97万元",
    "href": "http://stock.jrj.com.cn/2019/12/10220328518219.shtml",
    "datetime": "2019-12-10 22:03:32",
    "code": "600867"
  },
  {
    "title": "通化东宝：公司未入选2019年国家医保谈判目录的结论不成立",
    "href": "http://stock.jrj.com.cn/2019/12/03074428481056.shtml",
    "datetime": "2019-12-03 07:44:45",
    "code": "600867"
  },
  {
    "title": "机构抱团股翻车 8股创历史新高后回调超20%",
    "href": "http://stock.jrj.com.cn/2019/12/03050228480559.shtml",
    "datetime": "2019-12-03 05:02:42",
    "code": "600867"
  },
  {
    "title": "通化东宝：第九届董事会第二十三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/02233028480193.shtml",
    "datetime": "2019-12-02 23:30:04",
    "code": "600867"
  },
  {
    "title": "通化东宝：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/12/02233028480194.shtml",
    "datetime": "2019-12-02 23:30:04",
    "code": "600867"
  },
  {
    "title": "通化东宝将花不超2.6亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2019/12/02191228479242.shtml",
    "datetime": "2019-12-02 19:12:11",
    "code": "600867"
  },
  {
    "title": "通化东宝澄清：未入选2019年国家医保谈判目录的结论不成立",
    "href": "http://stock.jrj.com.cn/2019/12/02185028479140.shtml",
    "datetime": "2019-12-02 18:50:08",
    "code": "600867"
  },
  {
    "title": "通化东宝澄清：公司未入选2019年国家医保谈判目录的结论不成立",
    "href": "http://stock.jrj.com.cn/2019/12/02183328478753.shtml",
    "datetime": "2019-12-02 18:33:00",
    "code": "600867"
  },
  {
    "title": "数据复盘｜通化东宝遭机构净卖出逾3亿元 主力大举加仓这些股",
    "href": "http://stock.jrj.com.cn/invest/2019/12/02183228478746.shtml",
    "datetime": "2019-12-02 18:32:00",
    "code": "600867"
  },
  {
    "title": "通化东宝拟2亿元至2.6亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/12/02175728478578.shtml",
    "datetime": "2019-12-02 17:57:48",
    "code": "600867"
  },
  {
    "title": "通化东宝：拟2亿元至2.6亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/12/02171628478401.shtml",
    "datetime": "2019-12-02 17:16:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：拟斥资2亿-2.6亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/12/02171128478347.shtml",
    "datetime": "2019-12-02 17:11:23",
    "code": "600867"
  },
  {
    "title": "[通化东宝]忆峥嵘岁月 绘伟业宏图 东宝集团举行创立三十四周年茶话会",
    "href": "http://stock.jrj.com.cn/2019/12/01000030102253.shtml",
    "datetime": "2019-12-01 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]忆峥嵘岁月 绘伟业宏图 东宝集团举行创立三十四周年茶话会",
    "href": "http://stock.jrj.com.cn/2019/12/01000028474686.shtml",
    "datetime": "2019-12-01 00:00:00",
    "code": "600867"
  },
  {
    "title": "龙虎榜：通化东宝放量跌停 四机构卖出逾2亿元",
    "href": "http://stock.jrj.com.cn/2019/11/29171428469133.shtml",
    "datetime": "2019-11-29 17:14:00",
    "code": "600867"
  },
  {
    "title": "医药股大幅走弱 通化东宝逼近跌停",
    "href": "http://stock.jrj.com.cn/2019/11/29110628467448.shtml",
    "datetime": "2019-11-29 11:06:00",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1800万股 前三季度净利同比增长0.08%",
    "href": "http://stock.jrj.com.cn/2019/11/27192928459574.shtml",
    "datetime": "2019-11-27 19:29:40",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押671万股 2019年上半年净利同比下滑1%",
    "href": "http://stock.jrj.com.cn/2019/11/14091128397299.shtml",
    "datetime": "2019-11-14 09:11:41",
    "code": "600867"
  },
  {
    "title": "糖尿病药大杀价！通化东宝领衔概念股跳水 医保谈判有新情况",
    "href": "http://stock.jrj.com.cn/hotstock/2019/11/14064828396371.shtml",
    "datetime": "2019-11-14 06:48:45",
    "code": "600867"
  },
  {
    "title": "医保谈判糖尿病药大杀价 海思科股价跌停通化东宝跳水",
    "href": "http://stock.jrj.com.cn/2019/11/13134028392812.shtml",
    "datetime": "2019-11-13 13:40:48",
    "code": "600867"
  },
  {
    "title": "[通化东宝]中央扫黑除恶第13督导组来集团督导检查工作",
    "href": "http://stock.jrj.com.cn/2019/11/05000029809880.shtml",
    "datetime": "2019-11-05 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]中央扫黑除恶第13督导组来集团督导检查工作",
    "href": "http://stock.jrj.com.cn/2019/11/05000028353869.shtml",
    "datetime": "2019-11-05 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：参股公司特宝生物科创板上市申请获审核通过",
    "href": "http://stock.jrj.com.cn/2019/11/01161528339261.shtml",
    "datetime": "2019-11-01 16:15:46",
    "code": "600867"
  },
  {
    "title": "通化东宝：特宝生物科创板IPO获通过 公司持股33.94%",
    "href": "http://stock.jrj.com.cn/2019/11/01155528339199.shtml",
    "datetime": "2019-11-01 15:55:10",
    "code": "600867"
  },
  {
    "title": "通化东宝：参股公司特宝生物科创板首发过会",
    "href": "http://stock.jrj.com.cn/2019/11/01154228339138.shtml",
    "datetime": "2019-11-01 15:42:45",
    "code": "600867"
  },
  {
    "title": "通化东宝：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285035.shtml",
    "datetime": "2019-10-23 01:10:02",
    "code": "600867"
  },
  {
    "title": "通化东宝三季度净利6.88亿 同比增长0.08%",
    "href": "http://stock.jrj.com.cn/2019/10/22195128284302.shtml",
    "datetime": "2019-10-22 19:51:23",
    "code": "600867"
  },
  {
    "title": "通化东宝三季报净利微幅增长 北上资金连续两季度减持后现小幅增持",
    "href": "http://stock.jrj.com.cn/2019/10/22192528284181.shtml",
    "datetime": "2019-10-22 19:25:00",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1495万股 2019年上半年净利同比下滑0.85%",
    "href": "http://stock.jrj.com.cn/2019/10/16211228258249.shtml",
    "datetime": "2019-10-16 21:12:58",
    "code": "600867"
  },
  {
    "title": "通化东宝股东李一奎拟减持股份 预计减持不超总股本0.14%",
    "href": "http://stock.jrj.com.cn/2019/09/25212928180430.shtml",
    "datetime": "2019-09-25 21:29:36",
    "code": "600867"
  },
  {
    "title": "通化东宝：实控人之一李一奎拟减持不超过280万股 占比0.14％",
    "href": "http://stock.jrj.com.cn/2019/09/25170128178970.shtml",
    "datetime": "2019-09-25 17:01:38",
    "code": "600867"
  },
  {
    "title": "[通化东宝]提高身体素质 凝聚奋进精神 东宝集团举办第三届职工篮球比赛",
    "href": "http://stock.jrj.com.cn/2019/09/24000028171657.shtml",
    "datetime": "2019-09-24 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝拟投资设立全资子公司 注册资本1亿元",
    "href": "http://stock.jrj.com.cn/2019/09/16170228135937.shtml",
    "datetime": "2019-09-16 17:02:37",
    "code": "600867"
  },
  {
    "title": "通化东宝为加快产业科学布局 拟投资1亿元成立全资子公司",
    "href": "http://stock.jrj.com.cn/2019/09/16163928135850.shtml",
    "datetime": "2019-09-16 16:39:40",
    "code": "600867"
  },
  {
    "title": "通化东宝第一大股东东宝集团拟减持不超1%",
    "href": "http://stock.jrj.com.cn/2019/09/12174928127950.shtml",
    "datetime": "2019-09-12 17:49:24",
    "code": "600867"
  },
  {
    "title": "通化东宝：第一大股东东宝集团拟减持不超1%",
    "href": "http://stock.jrj.com.cn/2019/09/12170928127826.shtml",
    "datetime": "2019-09-12 17:09:56",
    "code": "600867"
  },
  {
    "title": "通化东宝高级管理人员陈红减持9万股 套现合计约158万元",
    "href": "http://stock.jrj.com.cn/2019/08/27105928039518.shtml",
    "datetime": "2019-08-27 10:59:37",
    "code": "600867"
  },
  {
    "title": "通化东宝：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/13004027964711.shtml",
    "datetime": "2019-08-13 00:40:20",
    "code": "600867"
  },
  {
    "title": "通化东宝：第九届董事会第十九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/13004027964712.shtml",
    "datetime": "2019-08-13 00:40:20",
    "code": "600867"
  },
  {
    "title": "通化东宝2019年上半年净利5.32亿 银行贷款利息增加",
    "href": "http://stock.jrj.com.cn/2019/08/12171527963037.shtml",
    "datetime": "2019-08-12 17:15:40",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团解除质押1100万股 新增质押1300万股",
    "href": "http://stock.jrj.com.cn/2019/08/07223927944393.shtml",
    "datetime": "2019-08-07 22:39:57",
    "code": "600867"
  },
  {
    "title": "通化东宝：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2019/07/28181027895819.shtml",
    "datetime": "2019-07-28 18:10:00",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1740万股 公司去年净利同比增长0.25%",
    "href": "http://stock.jrj.com.cn/2019/07/08074527807677.shtml",
    "datetime": "2019-07-08 07:45:58",
    "code": "600867"
  },
  {
    "title": "[通化东宝]集团党委组织开展“不忘初心 牢记使命 弘扬新时代雷锋精神”主题党日活动",
    "href": "http://stock.jrj.com.cn/2019/07/02000027785568.shtml",
    "datetime": "2019-07-02 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1800万股 公司去年净利同比增长0.25%",
    "href": "http://stock.jrj.com.cn/2019/06/23100227743430.shtml",
    "datetime": "2019-06-23 10:02:50",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1739万股 公司去年净利同比增长0.25%",
    "href": "http://stock.jrj.com.cn/2019/06/14081227702880.shtml",
    "datetime": "2019-06-14 08:12:13",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押2350万股 公司去年净利同比增长0.25%",
    "href": "http://stock.jrj.com.cn/2019/05/26091327623018.shtml",
    "datetime": "2019-05-26 09:13:28",
    "code": "600867"
  },
  {
    "title": "通化东宝2名股东拟减持股份 预计合计减持不超总股本0.01%",
    "href": "http://stock.jrj.com.cn/2019/05/22074227605436.shtml",
    "datetime": "2019-05-22 07:42:27",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团解除质押1150万股 新增质押1800万股",
    "href": "http://stock.jrj.com.cn/2019/05/16065527578544.shtml",
    "datetime": "2019-05-16 06:55:53",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/16004027575668.shtml",
    "datetime": "2019-05-16 00:40:08",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/10004027550000.shtml",
    "datetime": "2019-05-10 00:40:01",
    "code": "600867"
  },
  {
    "title": "[通化东宝]通化东宝药业股份有限公司召开2018年年度股东大会",
    "href": "http://stock.jrj.com.cn/2019/05/10000027553621.shtml",
    "datetime": "2019-05-10 00:00:00",
    "code": "600867"
  },
  {
    "title": "[通化东宝]打造和谐团队 提升优秀自我 东宝集团开展企业拓展实践活动",
    "href": "http://stock.jrj.com.cn/2019/05/09000027548711.shtml",
    "datetime": "2019-05-09 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝一季度净利2.74亿元 同比下滑0.06%",
    "href": "http://stock.jrj.com.cn/2019/04/26192027493134.shtml",
    "datetime": "2019-04-26 19:20:35",
    "code": "600867"
  },
  {
    "title": "通化东宝：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/26054027486305.shtml",
    "datetime": "2019-04-26 05:40:39",
    "code": "600867"
  },
  {
    "title": "通化东宝去年净利8.39亿元 同比增长0.2% 董事长冷春生年薪116万元",
    "href": "http://stock.jrj.com.cn/2019/04/17073127413258.shtml",
    "datetime": "2019-04-17 07:31:35",
    "code": "600867"
  },
  {
    "title": "通化东宝已布局新一代胰岛素产品",
    "href": "http://stock.jrj.com.cn/2019/04/16223627409415.shtml",
    "datetime": "2019-04-16 22:36:01",
    "code": "600867"
  },
  {
    "title": "通化东宝：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409174.shtml",
    "datetime": "2019-04-16 22:20:01",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409172.shtml",
    "datetime": "2019-04-16 22:20:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：第九届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/16222027409173.shtml",
    "datetime": "2019-04-16 22:20:00",
    "code": "600867"
  },
  {
    "title": "通化东宝交出李一奎任期内最后一份成绩单 北上资金去年四季度增持1537.42万股",
    "href": "http://stock.jrj.com.cn/2019/04/16191627408281.shtml",
    "datetime": "2019-04-16 19:16:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年净利8.39亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2019/04/16161327407065.shtml",
    "datetime": "2019-04-16 16:13:48",
    "code": "600867"
  },
  {
    "title": "通化东宝：门冬胰岛素注射液获得报产受理通知",
    "href": "http://stock.jrj.com.cn/2019/04/10162327361518.shtml",
    "datetime": "2019-04-10 16:23:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：西格列汀二甲双胍片（Ⅱ）注册申请获受理",
    "href": "http://stock.jrj.com.cn/2019/04/02154927307726.shtml",
    "datetime": "2019-04-02 15:49:01",
    "code": "600867"
  },
  {
    "title": "通化东宝：对特宝生物投资额占公司净资产比例较小 不构成重大影响",
    "href": "http://stock.jrj.com.cn/2019/03/28222827261222.shtml",
    "datetime": "2019-03-28 22:28:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：持股约34%的特宝生物申请科创板上市进程尚存不确定性",
    "href": "http://stock.jrj.com.cn/2019/03/28161427258941.shtml",
    "datetime": "2019-03-28 16:14:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：参股公司特宝生物申请科创板上市进程尚存不确定性",
    "href": "http://stock.jrj.com.cn/2019/03/28161127258889.shtml",
    "datetime": "2019-03-28 16:11:27",
    "code": "600867"
  },
  {
    "title": "特宝生物申请科创板获受理 通化东宝参股33.94%",
    "href": "http://stock.jrj.com.cn/2019/03/27184227251829.shtml",
    "datetime": "2019-03-27 18:42:44",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1142万股 公司去年前三季度利润增长6%",
    "href": "http://stock.jrj.com.cn/2019/03/27073727247449.shtml",
    "datetime": "2019-03-27 07:37:53",
    "code": "600867"
  },
  {
    "title": "通化东宝股东东宝集团质押1218万股 其持有的98%被质押",
    "href": "http://stock.jrj.com.cn/2019/03/24162927219443.shtml",
    "datetime": "2019-03-24 16:29:07",
    "code": "600867"
  },
  {
    "title": "通化东宝联营企业特宝生物拟申报科创板",
    "href": "http://stock.jrj.com.cn/2019/03/18144527183069.shtml",
    "datetime": "2019-03-18 14:45:15",
    "code": "600867"
  },
  {
    "title": "[通化东宝]肩负企业发展重任 砥砺前行再创辉煌 东宝集团召开机关干部扩大会议",
    "href": "http://stock.jrj.com.cn/2019/03/08000027137190.shtml",
    "datetime": "2019-03-08 00:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝董事、总经理李聪辞职 年薪117万元",
    "href": "http://stock.jrj.com.cn/2019/03/04215827116512.shtml",
    "datetime": "2019-03-04 21:58:32",
    "code": "600867"
  },
  {
    "title": "通化东宝：第九届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/04215027116466.shtml",
    "datetime": "2019-03-04 21:50:09",
    "code": "600867"
  },
  {
    "title": "通化东宝换帅 第一大股东董事长及法定代表人亦变更",
    "href": "http://stock.jrj.com.cn/2019/03/04210227116310.shtml",
    "datetime": "2019-03-04 21:02:00",
    "code": "600867"
  },
  {
    "title": "通化东宝大股东完成增持公司1.1%股份",
    "href": "http://stock.jrj.com.cn/2019/01/16195726915107.shtml",
    "datetime": "2019-01-16 19:57:44",
    "code": "600867"
  },
  {
    "title": "通化东宝：大股东完成增持公司1.1%股份",
    "href": "http://stock.jrj.com.cn/2019/01/16181026914542.shtml",
    "datetime": "2019-01-16 18:10:56",
    "code": "600867"
  },
  {
    "title": "通化东宝：大股东拟斥资2亿至3亿元增持股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/18080026757715.shtml",
    "datetime": "2018-12-18 08:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝大股东拟2亿至3亿元增持股份",
    "href": "http://stock.jrj.com.cn/2018/12/17182626755397.shtml",
    "datetime": "2018-12-17 18:26:31",
    "code": "600867"
  },
  {
    "title": "通化东宝：大股东拟2亿至3亿元增持股份",
    "href": "http://stock.jrj.com.cn/2018/12/17181826755360.shtml",
    "datetime": "2018-12-17 18:18:42",
    "code": "600867"
  },
  {
    "title": "通化东宝：大股东拟2亿至3亿元增持股份",
    "href": "http://stock.jrj.com.cn/2018/12/17181726755359.shtml",
    "datetime": "2018-12-17 18:17:00",
    "code": "600867"
  },
  {
    "title": "通化东宝顶格3亿元实施回购 回购股份将注销",
    "href": "http://stock.jrj.com.cn/2018/12/11004525505672.shtml",
    "datetime": "2018-12-11 00:45:01",
    "code": "600867"
  },
  {
    "title": "通化东宝净利降逾三成 大股东质押97%股权风险隐存",
    "href": "http://stock.jrj.com.cn/2018/12/04073825445458.shtml",
    "datetime": "2018-12-04 07:38:47",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/13231025341089.shtml",
    "datetime": "2018-11-13 23:10:01",
    "code": "600867"
  },
  {
    "title": "三季报业绩突变脸 通化东宝增速放缓",
    "href": "http://stock.jrj.com.cn/2018/11/06053125308354.shtml",
    "datetime": "2018-11-06 05:31:20",
    "code": "600867"
  },
  {
    "title": "通化东宝两跌停打脸国泰君安：两个月前喊目标价29元",
    "href": "http://stock.jrj.com.cn/2018/10/29141725272224.shtml",
    "datetime": "2018-10-29 14:17:16",
    "code": "600867"
  },
  {
    "title": "通化东宝季度业绩骤降 国产胰岛素龙头怎么了？",
    "href": "http://stock.jrj.com.cn/2018/10/29070225270203.shtml",
    "datetime": "2018-10-29 07:02:30",
    "code": "600867"
  },
  {
    "title": "通化东宝：关于召开2018年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/10/26231625266538.shtml",
    "datetime": "2018-10-26 23:16:50",
    "code": "600867"
  },
  {
    "title": "通化东宝：第九届董事会第十五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/26231625266537.shtml",
    "datetime": "2018-10-26 23:16:46",
    "code": "600867"
  },
  {
    "title": "通化东宝拟回购公司股份至多3亿元 不超过24元/股",
    "href": "http://stock.jrj.com.cn/2018/10/26180625265183.shtml",
    "datetime": "2018-10-26 18:06:30",
    "code": "600867"
  },
  {
    "title": "通化东宝归因压缩铺货量保资金安全",
    "href": "http://stock.jrj.com.cn/2018/10/26013425261372.shtml",
    "datetime": "2018-10-26 01:34:49",
    "code": "600867"
  },
  {
    "title": "三季报业绩不及预期 通化东宝股价跌停",
    "href": "http://stock.jrj.com.cn/2018/10/25111125258015.shtml",
    "datetime": "2018-10-25 11:11:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/24233025255877.shtml",
    "datetime": "2018-10-24 23:30:03",
    "code": "600867"
  },
  {
    "title": "通化东宝：重组赖脯胰岛素注射液获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/15080025202314.shtml",
    "datetime": "2018-10-15 08:00:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：重组赖脯胰岛素注射液获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/10/12170525196309.shtml",
    "datetime": "2018-10-12 17:05:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：利拉鲁肽及注射液获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/10/11155025188098.shtml",
    "datetime": "2018-10-11 15:50:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：业绩基本符合预期 静待三代胰岛素上市",
    "href": "http://stock.jrj.com.cn/2018/08/16094724960508.shtml",
    "datetime": "2018-08-16 09:47:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：业绩符合预期 研发管线持续推进",
    "href": "http://stock.jrj.com.cn/2018/08/16094524960509.shtml",
    "datetime": "2018-08-16 09:45:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：业绩符合预期，研发管线持续推进",
    "href": "http://stock.jrj.com.cn/2018/08/15144424954874.shtml",
    "datetime": "2018-08-15 14:44:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：业绩基本符合预期，静待三代胰岛素上市",
    "href": "http://stock.jrj.com.cn/2018/08/15144324954869.shtml",
    "datetime": "2018-08-15 14:43:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：业绩符合预期 期待三代胰岛素",
    "href": "http://stock.jrj.com.cn/2018/08/15092424953448.shtml",
    "datetime": "2018-08-15 09:24:00",
    "code": "600867"
  },
  {
    "title": "通化东宝：上半年净利5.37亿元 同比增逾三成",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/15075924952864.shtml",
    "datetime": "2018-08-15 07:59:58",
    "code": "600867"
  },
  {
    "title": "通化东宝：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/14212024951507.shtml",
    "datetime": "2018-08-14 21:20:06",
    "code": "600867"
  }
]